image
Immunic, Inc. IMUX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.06
-2.75 %
$ 95.5 M
Market Cap
-0.86
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-99.2 M OPERATING INCOME
16.96%
Growth Rates
1Year 16.96%
3Years -26.54%
5Years -18.75%
7Years -13.35%
10Years -12.19%
-93.6 M NET INCOME
22.25%
Growth Rates
1Year 22.25%
3Years -28.60%
5Years -17.68%
7Years -12.53%
10Years -11.08%
EFFICIENCY
Earnings Waterfall Immunic, Inc.
image
Revenue 0
Cost Of Revenue 111 K
Gross Profit -111 K
Operating Expenses 99.2 M
Operating Income -99.2 M
Other Expenses -5.61 M
Net Income -93.6 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 0 0 0 0 0 0 0 6.32 K 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 0.1 77 K 85 K 39 K 50 K 15 K 1.0 1.8 1.3 0 0 0 0
Gross Profit (0.1) 77 K 85 K 39 K 50 K 15 K (1.0) (1.8) (1.3) 0 0 0 0
OPERATING INCOME
Operating Expenses 99.2 86.5 91.7 49.0 37.0 38.4 52.7 41.3 52.1 50.3 31.4 9.6 8.6
Selling, General and Administrative Expenses 16.0 15.3 13.3 10.3 14.5 13.6 13.3 11.2 12.3 10.9 9.6 4.5 3.1
Research and Development Expenses 83.2 71.3 61.1 38.6 22.5 24.8 39.3 30.0 39.8 39.5 21.8 5.1 5.5
Operating Income (99.2) (119.5) (91.7) (49.0) (37.0) (42.0) (52.7) (41.3) (52.1) (50.3) (31.4) (9.6) (8.6)
PRE-TAX INCOME
Interest Income Expense 0 1.0 0 0 0.1 0 0 0 0 0 0 0.4 9.2
Total Other Income 5.6 (0.9) (1.3) 5.0 2.1 0.5 0.6 0.3 97 K 2.7 (1.3) 40 K 2.7
Pre-Tax Income (93.6) (120.4) (92.9) (44.0) (34.9) (41.5) (52.1) (41.0) (52.0) (47.7) (32.7) (6.7) (5.9)
NET INCOME
Tax Provision 0 33.9 (0.2) 58 K (0.1) 0.5 (0.6) (1.8) (1.3) (1.1) 0 0.4 9.2
Net Income (93.6) (154.3) (92.8) (44.0) (34.8) (41.5) (52.1) (41.0) (52.0) (47.7) (32.7) (6.7) (5.9)
EPS 2.11 4.85 3.92 2.81 4.51 39.2 52.3 52.2 82.7 80 2.32 K 475 417